Dawn C. Buse, PhD
Advertisement
Articles by Dawn C. Buse, PhD
Reducing the frequency of migraine is only 1 step in the process of optimizing management and addressing the disease's impact on patients’ lives.
Advertisement
Latest Updated Articles
Patient Selection of Novel Therapies for Migraine TreatmentPublished: October 28th 2020 | Updated:
Unmet Needs in the Management of MigrainePublished: October 28th 2020 | Updated:
Behavioral and Lifestyle Strategies for Migraine ManagementPublished: October 28th 2020 | Updated:
Acute Treatment of Migraine: Traditional TherapiesPublished: October 28th 2020 | Updated:
Role of Neuromodulation for Acute Treatment of MigrainePublished: October 28th 2020 | Updated:
Evolution of Acute Treatment of MigrainePublished: October 28th 2020 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Understanding VTX3232’s Effects on Patients with Early-Stage Parkinson Disease
2
FDA Accepts New Drug Application for Tau PET Imaging Agent MK-6240 in Alzheimer Disease
3
Ocrelizumab’s Encouraging Treatment Effects Across Conception Delivery and Breastfeeding
4
Exenatide Alters Motor Network Activity in Parkinson Disease, Though Clinical Impact Remains Limited
5
